Keen to bag the latest NIB dividend? Time is running out

ASX investors will have to be quick if they want to secure NIB's latest dividend…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • NIB shares are having a tough day today
  • But the health insurance giant is set for another rough day next Monday
  • That's because NIB is scheduled to trade ex-dividend...

It's been a rather sad end to the trading week for the NIB Holdings Limited (ASX: NHF) share price so far this Friday. At the time of writing, NIB shares have endured a 0.99% drop to $8 a share.

That stands in contrast to the broader S&P/ASX 200 Index (ASX: XJO). The ASX 200 has currently banked a tentative gain of 0.08% to around 6,850 points.

It's unclear what is causing investors to have some trepidation about NIB shares as we end the trading week today. But there's one thing we know for sure. The NIB share price is set for another tough day next Monday.

How can we know this? Well, that's when NIB is scheduled to trade ex-dividend for its upcoming final dividend payment.

A woman has a thoughtful look on her face as she studies a fan of Australian 20 dollar bills she is holding on one hand while he rest her other hand on her chin in thought.

Image source: Getty Images

The NIB dividend is coming, but you'll have to be quick

NIB announced its full-year earnings report for FY22 last month. At the time, the health insurance giant declared a final dividend of 11 cents per share, fully franked. This was a 21.4% decline from the final dividend of 14 cents per share that the company paid out last year for FY21.

It will take NIB's full-year dividends for FY22 to 22 cents per share. That follows April's interim dividend that was also worth 11 cents per share.

Again, that's a drop from FY21's total of 24 cents per share.

But if investors want to receive this dividend, they will have to act quickly. Monday's ex-dividend date means that today is the last day an investor can buy NIB shares to become eligible for this upcoming dividend. From Monday, new shareholders will be cut off.

This is why we are almost certainly set to see NIB shares go backwards during Monday's session. No new investors will be eligible for the final dividend come Monday. As such, the value of this dividend will leave the NIB share price. That's what normally happens when an ASX share goes ex-dividend.

Investors (or those eligible, anyway) will then have to wait until 4 October to see the dividend hit their bank accounts. NIB is offering shareholders the option of participating in the company's dividend reinvestment plan (DRP) though.

So if any investors wish to receive new NIB shares in lieu of cash, they have until 7 September to make this known to the company.

At the current NIB share price, this ASX 200 insurance share has a market capitalisation of $3.67 billion, with a dividend yield of 2.75%.

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended NIB Holdings Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Shot of a young scientist using a digital tablet while working in a lab.
Healthcare Shares

Australian Clinical Labs delivers profit growth and stronger margins in FY26

Australian Clinical Labs’ FY26 earnings reveal profit growth and margin improvements despite market headwinds.

Read more »

medical research laboratory assistant examines solutions in test tubes
Healthcare Shares

CSL shares are rallying. Could tomorrow's results pour fuel on the fire?

One strong month isn't enough. CSL needs earnings recovery to follow.

Read more »

A man with a perplexed expression on his face scratches his head.
Healthcare Shares

4DMedical shares are up 670% — but why have they halved?

Can the company turn its commercial momentum into another explosive share-price rebound?

Read more »

Businesswoman with a pleased smile reading on her laptop at a desk in the office with a look of satisfaction.
Healthcare Shares

Are CSL shares dirt cheap and a strong buy?

There is plenty for CSL to prove next week. The current valuation is why I am still interested.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Healthcare Shares

Why this ASX healthcare stock is a top rebound candidate with big upside 

This could be a perfect buy-low candidate.

Read more »

Doctor sees virtual images of the patient's x-rays on a blue background.
Healthcare Shares

2 ASX healthcare stocks tipped to return 34% to 63%

These companies could be poised for much bigger things.

Read more »

Smiling couple looking at a phone at a bargain opportunity.
ASX Share Market News

Are Pro Medicus shares now too cheap to ignore?

The discount looks tempting, but slowing growth could expose valuation risks.

Read more »

Two ASX share investors sharing a secret.
Healthcare Shares

Cochlear shares are quietly rebounding: Is a bigger rally coming?

After a 58% plunge, Cochlear doesn’t need perfection to surprise investors.

Read more »